Evotec SE EVTCY:OTCPK

RT Quote | Exchange | USD
Last | 03/05/21 EST
70.25UNCH (UNCH)
Volume
114
52 week range
40.42 - 90.14

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close70.25
  • 52 Week High90.14
  • 52 Week High Date02/16/21
  • 52 Week Low40.42
  • 52 Week Low Date03/23/20
  • Market Cap5,310.9M
  • Shares Out75.6M
  • 10 Day Average Volume701.63
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • 1 Year % Change42.78

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Evotec SE News

There is no recent news for this security.

Latest EVTCY News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug...
Werner Lanthaler Ph.D.
Chief Executive Officer
Craig Johnstone
Chief Operating Officer
Enno Spillner
Chief Financial Officer
Address
Essener Bogen 7
Hamburg
22419
Germany